Paper40564985
Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology.
Jannati S and 3 others. Int J Mol Sci, 2025. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology. Papers, record 40564985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40564985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Neoplasms | Major topic |
| Cyclopentane Monoterpenes | Major topic |
| Aldehydes | Major topic |
| Humans | |
| Precision Medicine | |
| Animals | |
| Drug Delivery Systems | |
| Phenols |
Source PubMed
References217
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34063828 | Inflammation-Induced Tumorigenesis and Metastasis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34063828 | PubMed |
| 2 | 15066921 | Dietary patterns and risk of breast cancer in the ORDET cohort. | Cancer Epidemiol Biomarkers Prev | 2004 | https://conductscience.org/library/papers/15066921 | PubMed |
| 3 | 20947337 | Consumption of animal products, olive oil and dietary fat and results from the Belgian case-control study on bladder cancer risk. | Eur J Cancer | 2011 | https://conductscience.org/library/papers/20947337 | PubMed |
| 4 | 10645813 | Prostate cancer and dietary carotenoids. | Am J Epidemiol | 2000 | https://conductscience.org/library/papers/10645813 | PubMed |
| 5 | 16512965 | Olive oil consumption and risk of breast cancer in the Canary Islands: a population-based case-control study. | Public Health Nutr | 2006 | https://conductscience.org/library/papers/16512965 | PubMed |
| 6 | 38136231 | Oleocanthal, an Antioxidant Phenolic Compound in Extra Virgin Olive Oil (EVOO): A Comprehensive Systematic Review of Its Potential in Inflammation and Cancer. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/38136231 | PubMed |
| 7 | 34088913 | Protein suppresses both bitterness and oleocanthal-elicited pungency of extra virgin olive oil. | Sci Rep | 2021 | https://conductscience.org/library/papers/34088913 | PubMed |
| 8 | 23584393 | Extracellular vesicles: biology and emerging therapeutic opportunities. | Nat Rev Drug Discov | 2013 | https://conductscience.org/library/papers/23584393 | PubMed |
| 9 | 37910854 | Pharmacokinetics and Metabolism Investigation of Oleocanthal. | J Nat Prod | 2024 | https://conductscience.org/library/papers/37910854 | PubMed |
| 10 | 38254699 | A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment. | Biomolecules | 2024 | https://conductscience.org/library/papers/38254699 | PubMed |
| 11 | 36771326 | S-(-)-Oleocanthal Ex Vivo Modulatory Effects on Gut Microbiota. | Nutrients | 2023 | https://conductscience.org/library/papers/36771326 | PubMed |
| 12 | 39806451 | Emerging role of exosomes in cancer therapy: progress and challenges. | Mol Cancer | 2025 | https://conductscience.org/library/papers/39806451 | PubMed |
| 13 | 39064815 | Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers. | Nutrients | 2024 | https://conductscience.org/library/papers/39064815 | PubMed |
| 14 | 25037503 | The pentose phosphate pathway and cancer. | Trends Biochem Sci | 2014 | https://conductscience.org/library/papers/25037503 | PubMed |
| 15 | 26244666 | Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status. | PLoS One | 2015 | https://conductscience.org/library/papers/26244666 | PubMed |
| 16 | 34445193 | Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445193 | PubMed |
| 17 | 39200224 | The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases. | Biomedicines | 2024 | https://conductscience.org/library/papers/39200224 | PubMed |
| 18 | 36139600 | Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36139600 | PubMed |
| 19 | 35912181 | Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer. | Front Oncol | 2022 | https://conductscience.org/library/papers/35912181 | PubMed |
| 20 | 37131291 | Crohn's disease proteolytic microbiota enhances inflammation through PAR2 pathway in gnotobiotic mice. | Gut Microbes | 2023 | https://conductscience.org/library/papers/37131291 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42738930 | Time-Dependent Multimechanistic Antitumor Effects of Olive Oil Phenolics in a Triple-Negative Breast Cancer Mouse Model. | Nutrients | 2026 | https://conductscience.org/library/papers/42738930 | PubMed |
| 42737430 | Protease-Activated Receptor-2 as a Proteolytic Rheostat in Colorectal and Pancreatic Cancer: From Mechanism to Biomarker-Guided Therapy. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737430 | PubMed |
| 42654203 | Lead Validation of the Olive Phenolic S-(-)-Oleocanthal for Effective Control of KRASG13D-Mutant Colorectal Cancer Progression and Metastasis. | Nutrients | 2026 | https://conductscience.org/library/papers/42654203 | PubMed |
| 42589399 | Rosmarinic Acid Sensitizes Ovarian Cancer Cells to Gemcitabine Through Oxidative Stress-Associated Apoptotic and Antiproliferative Responses. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589399 | PubMed |
| 42588034 | Nutraceuticals in Uro-Oncology: A Structured Expert Review and Precision-Oriented Framework. | Nutrients | 2026 | https://conductscience.org/library/papers/42588034 | PubMed |
| 42583093 | Exploring the molecular basis of Panax notoginseng mediated inhibition of cervical cancer through machine learning, transcriptomics analysis, network pharmacology, molecular docking, and in-silico simulation approaches. | Bioinform Adv | 2026 | https://conductscience.org/library/papers/42583093 | PubMed |
| 42301532 | Programmed cell death and metastatic evolution in breast cancer: the role of anoikis, necroptosis, and ferroptosis. | Apoptosis | 2026 | https://conductscience.org/library/papers/42301532 | PubMed |
| 42072053 | Oleocanthal Induces Mitochondrial Dysfunction in Breast Cancer Cell Lines Depending on c-MET Expression. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42072053 | PubMed |
| 42053656 | Immunotherapy for depression: targeting cytokine pathways in major depressive disorder. | Psychopharmacology (Berl) | 2026 | https://conductscience.org/library/papers/42053656 | PubMed |
| 42004177 | Taoren Honghua Jian Regulate NLRP3 Inflammasome of Coronary Artery Disease Patients: A Multi-Center, Double-Blind, Randomized Controlled Trial. | Vasc Health Risk Manag | 2026 | https://conductscience.org/library/papers/42004177 | PubMed |
| 41832248 | Next generation approaches in cancer immunotherapy targeting mechanisms beyond PD1 and PDL1. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41832248 | PubMed |
| 41438572 | Oxidative stability of extra virgin olive oil assessed by electron paramagnetic resonance, chemical composition, and multivariate analysis. | Curr Res Food Sci | 2026 | https://conductscience.org/library/papers/41438572 | PubMed |
| 41160113 | GPCR Biased Signaling in Cancer. | Handb Exp Pharmacol | 2026 | https://conductscience.org/library/papers/41160113 | PubMed |
| 41156614 | In Vitro Inhibition of Cryptosporidium parvum Infection by the Olive Oil Component Oleocanthal. | Pathogens | 2025 | https://conductscience.org/library/papers/41156614 | PubMed |
| 41009479 | In Silico and In Vitro Studies of Anti-Inflammatory, Anti-Oxidative Stress, and Anti-Apoptosis Effect of 7-Octenoic Acid Derived from Moringa oleifera Lam., on LPS-Induced Monocyte-Derived Macrophages (MDM). | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009479 | PubMed |
| 40943351 | Molecular and Immunomodulatory Mechanisms of Statins in Inflammation and Cancer Therapeutics with Emphasis on the NF-κB, NLRP3 Inflammasome, and Cytokine Regulatory Axes. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943351 | PubMed |
| 40807332 | Harnessing Nature's Chemistry: Deciphering Olive Oil Phenolics for the Control of Invasive Breast Carcinoma. | Molecules | 2025 | https://conductscience.org/library/papers/40807332 | PubMed |
| 40647462 | Exploring Experimental Models of Colorectal Cancer: A Critical Appraisal from 2D Cell Systems to Organoids, Humanized Mouse Avatars, Organ-on-Chip, CRISPR Engineering, and AI-Driven Platforms-Challenges and Opportunities for Translational Precision Oncology. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40647462 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40564985
GET https://conductscience.org/api/papers/v1/40564985/references?page=2